306 Publications (Page 7 of 13)
2007
Depressed mood in informal caregivers of individuals with mild cognitive impairment.
Lu, Yvonne Y⋅Austrom, Mary G⋅Perkins, Susan M⋅Bakas, Tamilyn⋅Farlow, Martin R⋅He, Feng⋅Jin, Shelia and Gamst, Anthony
American journal of Alzheimer's disease and other dementias, vol. 22, (no. 4), pp. 273-85, 2007 Aug-Sep. | Journal Article
 
Effective Pharmacologic Management of Alzheimer's Disease
Farlow, Martin R and Cummings, Jeffrey L
The American Journal of Medicine, vol. 120, (no. 5), pp. 388-397, May 2007. | Journal Article
 
Efficacy and safety of galantamine in patients with dementia with Lewy bodies: a 24-week open-label study.
Edwards, Keith⋅Royall, Donald⋅Hershey, Linda⋅Lichter, David⋅Hake, Ann⋅Farlow, Martin⋅Pasquier, Florence and Johnson, Stewart
Dementia and geriatric cognitive disorders, vol. 23, (no. 6), pp. 401-5, 2007. | Journal Article
 
Quantitative analysis of amyloid-[beta] peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry
Gelfanova, Valentina⋅Higgs, Richard E⋅Dean, Robert A⋅Holtzman, David M⋅Farlow, Martin R⋅Siemers, Eric R⋅Boodhoo, Amechand⋅Qian, Yue-Wei⋅He, Xiaohua⋅Jin, Zhaoyan⋅Fisher, Deborah L⋅Cox, Karen L and Hale, John E
Briefings in Functional Genomics & Proteomics, vol. 6, (no. 2), pp. 149-58, Jun 2007. | Journal Article
 
Rivastigmine three times daily improves cognition and response in Alzheimer's disease
Farlow, Martin R
Evidence-based mental health, vol. 10, (no. 4), pp. 116, 2007-Nov. | Journal Article
 
Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretase.
Siemers, Eric R⋅Dean, Robert A⋅Friedrich, Stuart⋅Ferguson-Sells, Lisa⋅Gonzales, Celedon⋅Farlow, Martin R and May, Patrick C
Clinical neuropharmacology, vol. 30, (no. 6), pp. 317-25, 2007 Nov-Dec. | Journal Article
 
Safety, Tolerability, and Effects on Plasma and Cerebrospinal Fluid Amyloid-β After Inhibition of γ-Secretase
Siemers, Eric R⋅Dean, Robert A⋅Friedrich, Stuart⋅Ferguson-Sells, Lisa⋅Gonzales, Celedon⋅Farlow, Martin R and May, Patrick C
Clinical neuropharmacology, vol. 30, (no. 6), pp. 325, 2007 Nov-Dec. | Journal Article
2006
Age and Apolipoprotein E*4 Allele Effects on Cerebrospinal Fluid beta -Amyloid 42 in Adults With Normal Cognition
Peskind, Elaine R⋅Li, Gail⋅Shofer, Jane⋅Quinn, Joseph F⋅Kaye, Jeff⋅Clark, Christopher M⋅Farlow, Martin R⋅De Carli, Charles D⋅Raskind, Murray⋅Schellenberg, Gerard D⋅Lee, Virginia M and Galasko, Douglas R
Archives of Neurology, vol. 63, (no. 7), pp. 936-939, 2006. | Journal Article
 
Age and Apolipoprotein E4 Allele Effects on Cerebrospinal Fluid β-Amyloid 42 in Adults With Normal Cognition
Peskind, Elaine R⋅Li, Ge⋅Shofer, Jane⋅Quinn, Joseph F⋅Kaye, Jeffrey A⋅Clark, Chris M⋅Farlow, Martin R⋅DeCarli, Charles⋅Raskind, Murray A⋅Schellenberg, Gerard D⋅Lee, Virginia M.-Y and Galasko, Douglas R
Archives of Neurology, vol. 63, (no. 7), pp. 939, 2006-07-01. | Journal Article
 
Do cholinergic therapies have disease modifying effects in Alzheimer disease?
MN Sabbagh⋅Farlow, Martin R⋅N Relkin and TG Beach
Alzheimer & Dementia, vol. 2, pp. 118-125, 2006. | Journal Article
 
Do cholinergic therapies have disease-modifying effects in Alzheimer's disease?
Sabbagh, Marwan N⋅Farlow, Martin R⋅Relkin, Normal and Beach, Thomas G
Alzheimer's & dementia : the journal of the Alzheimer's Association, vol. 2, (no. 2), pp. 118-25, 2006/Apr. | Journal Article
 
Pharmacology for the cognitive symptoms of dementia
Farlow, Martin R
In Handbook of Dementing Illnesses. Taylor and Francis Group. 2006. | Book Chapter
 
High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression.
Sokol, Deborah K⋅Chen, Demao⋅Farlow, Martin R⋅Dunn, David W⋅Maloney, Bryan⋅Zimmer, Jennifer A and Lahiri, Debomoy K
Journal of child neurology, vol. 21, (no. 6), pp. 444-9, 2006/Jun. | Journal Article
 
O4-03-04
Siemers, Eric R⋅Benson, Charles⋅Gonzales, Celedon⋅Hansen, Ryan⋅Dean, Robert A⋅Farlow, Martin R and DeMattos, Ronald
Alzheimer's & Dementia, vol. 2, (no. 3), pp. S80, 2006-07-00. | Journal Article
 
P3-073
Hake, Ann Marie and Farlow, Martin R
Alzheimer's & Dementia, vol. 2, (no. 3), pp. S394, 2006-07-00. | Journal Article
 
P4-109
Spina, Salvatore⋅Spina, Salvatore⋅Murrell, Jill R⋅Murrell, Jill R⋅Farlow, Martin R⋅Farlow, Martin R⋅Ghetti, Bernardino and Ghetti, Bernardino
Alzheimer's & Dementia, vol. 2, (no. 3), pp. S546, 2006-07-00. | Journal Article
 
Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
Oe, Tomoyuki⋅Ackermann, Bradley L⋅Inoue, Koichi⋅Berna, Michael J⋅Garner, Carlos O⋅Gelfanova, Valentina⋅Dean, Robert A⋅Siemers, Eric R⋅Holtzman, David M⋅Farlow, Martin R and Blair, Ian A
Rapid communications in mass spectrometry : RCM, vol. 20, (no. 24), pp. 3723-35, 2006. | Journal Article
 
Quantitative analysis of amyloid β peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry
Oe, Tomoyuki⋅Ackermann, Bradley L⋅Inoue, Koichi⋅Berna, Michael J⋅Garner, Carlos O⋅Gelfanova, Valentina⋅Dean, Robert A⋅Siemers, Eric R⋅Holtzman, David M⋅Farlow, Martin R and Blair, Ian A
Rapid Communications in Mass Spectrometry, vol. 20, (no. 24), pp. 3735, 30 December 2006. | Journal Article
 
Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
Fillit, Howard M⋅Doody, Rachelle S⋅Binaso, Kimberly⋅Crooks, Glenna M⋅Ferris, Steven H⋅Farlow, Martin R⋅Leifer, Bennett⋅Mills, Charles⋅Minkoff, Neil⋅Orland, Burton⋅Reichman, William E and Salloway, Stephen P
The American journal of geriatric pharmacotherapy, vol. 4 Suppl A, pp. S9-S24; quiz S25-S28, 2006. | Journal Article
 
Recommendations for Best Practices in the Treatment of Alzheimer's Disease in Managed Care
Fillit, HM⋅Doody, Rachelle S⋅Binaso, K.⋅Crooks, GM⋅Ferris, Steven H⋅Farlow, Martin R⋅Leifer, B.⋅Mills, C.⋅Minkoff, N.⋅Orland, B.⋅Reichman, WE and Salloway, Stephen P
American Journal of Geriatric Pharmacotherapy, vol. 4, pp. p. S9, 2006. | Journal Article
 
Use of antidementia agents in vascular dementia: Beyond Alzheimer disease
Farlow, Martin R
Mayo Clinic Proceedings, vol. 81, pp. 1350-1358, 2006. | Journal Article
 
Use of Antidementia Agents in Vascular Dementia: Beyond Alzheimer Disease
Farlow, Martin R
Mayo Clinic Proceedings, vol. 81, (no. 10), pp. 1350-8, Oct 2006. | Journal Article
2005
A mutation in myotilin causes spheroid body myopathy
T Foroud⋅N Pankratz⋅AP Batchman⋅MW Pauciulo⋅R Vidal⋅L Miravalle⋅HH Goebel⋅LJ Cushman⋅B Azzarelli⋅H Horak⋅Farlow, Martin R and WC Nichols
Neurology, vol. 56, pp. 1936-1940, 2005. | Journal Article
 
A mutation in myotilin causes spheroid body myopathy
T Foroud⋅N Pankratz⋅AP Batchman⋅MW Pauciulo⋅R Vidal⋅L Miravalle⋅HH Goebel⋅LJ Cushman⋅B Azzarelli⋅H Horak⋅Farlow, Martin R and WC Nichols
Neurology, vol. 56, pp. 1936-1940, 2005. | Journal Article
 
A mutation in myotilin causes spheroid body myopathy.
Foroud, Tatiana M⋅Pankratz, Nathan⋅Batchman, A P⋅Pauciulo, M W⋅Vidal, R⋅Miravalle, L⋅Goebel, H H⋅Cushman, L J⋅Azzarelli, B⋅Horak, Holli⋅Farlow, Martin R and Nichols, W C
Neurology, vol. 65, (no. 12), pp. 1936-40, 2005/Dec/27. | Journal Article